Novo weight-loss drug may preserve lean body mass better than Lilly's, study finds

By Nancy Lapid April 16 (Reuters) - Eli Lilly's GLP-1 drug tirzepatide yields greater weight loss on average than Novo ...
Harvard Business Review

Building the AI-Powered Organization

Technology isn’t the biggest challenge. Culture is. by Tim Fountaine, Brian McCarthy and Tamim Saleh Artificial intelligence is reshaping business—though not at the blistering pace many assume. True, ...
Neurology Advisor

Eptinezumab Shows Modest Long-Term Efficacy in Refractory Chronic Migraine

Researchers evaluated the long-term effectiveness of eptinezumab on headache frequency, pain intensity, and disability in ...